SecBot SecBot

PBSV

Pharma-Bio Serv, Inc.
OTC· Services-Management Consulting Services· CIK 0001304161 Services
$0.4500 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $0.4500
Median target
$1.55
+244% · range $1.55–1.55
1 year
−30.8%
from $0.6500 · Oct 27
30 days
+28.6%
from $0.3500
52-week range
$0.3500–0.6500
−31% from high · low Sep 28
Avg volume 20D
5.6K
Oct 2 spike 55.6K
Short interest
958
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score
Strongest NEUTRAL Pharma-Bio Serv reported Q2 2026 (quarter ended April 30, 2026) results with revenues of approximately…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • EstimatesFLAT

    Current-quarter EPS estimate $0.030 → $0.030 over 90 days.

  • TrendDOWNTREND

    6% below its 50-day average.

The Street

12-month targets · 1 analysts

Price is below the lowest target. Median implies +244%.Targets as of Oct 26, 2026.

Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 14, 2026
Earnings date
PBSV Q3 2026 Earnings Scheduled — 2026-09-14
Jun 17, 2026
Earnings date
PBSV Q2 2026 Earnings Scheduled — 2026-06-17
Mar 12, 2026
Earnings date
PBSV Q1 2026 Earnings Scheduled — 2026-03-12

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jun 9, 2026
SPINDEL HOWARD
Director
OTHER42,504 sh

Earnings setup

Estimates
$0.03
EPS estimate, this quarter
0%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.03$0.03–$0.03+0.0%$2.7M
Next Q$0.02$0.02–$0.02+0.0%$2.6M
Current FY$0.04$0.04–$0.04-42.9%$11.0M
Next FY$0.11$0.11–$0.11+0.0%$12.9M

Short side

FINRA· Sep 30, 2026
958
shares short
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 14, 2026 Earnings calendar
PBSV Q3 2026 Earnings Scheduled — 2026-09-14
Jun 15, 2026 SEC
Pharma-Bio Serv reported Q2 2026 (quarter ended April 30, 2026) results with revenues of approximately $2.7M, up…
8-K — Impact 4/10
Jun 9, 2026 Insider
SPINDEL HOWARD disposed of 42,504 shares
Director

SecBot reports

1 filing · 0 bullish · 0 bearish · 1 neutral
All PBSV filing & press-release reports (1)